أعرض في EDS

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions.

التفاصيل البيبلوغرافية
العنوان: Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions.
المؤلفون: Schriek AI; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands., van Haaren MM; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands., Poniman M; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands., Dekkers G; QVQ Holding BV, Utrecht, Netherlands., Bentlage AEH; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Grobben M; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands., Vidarsson G; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Sanders RW; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, United States., Verrips T; Department of Biology, Faculty of Sciences, Utrecht University, Utrecht, Netherlands.; VerLin BV, Utrecht, Netherlands., Geijtenbeek TBH; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands., Heukers R; QVQ Holding BV, Utrecht, Netherlands., Kootstra NA; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands., de Taeye SW; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands., van Gils MJ; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.
المصدر: Frontiers in immunology [Front Immunol] 2022 Nov 22; Vol. 13, pp. 1091668. Date of Electronic Publication: 2022 Nov 22 (Print Publication: 2022).
نوع المنشور: Published Erratum
اللغة: English
بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE; MEDLINE
أسماء مطبوعة: Original Publication: [Lausanne : Frontiers Research Foundation]
مستخلص: [This corrects the article DOI: 10.3389/fimmu.2022.893648.].
(Copyright © 2022 Schriek, van Haaren, Poniman, Dekkers, Bentlage, Grobben, Vidarsson, Sanders, Verrips, Geijtenbeek, Heukers, Kootstra, de Taeye and van Gils.)
التعليقات: Erratum for: Front Immunol. 2022 May 16;13:893648. (PMID: 35651621)
فهرسة مساهمة: Keywords: Fc fusion; Fc-mediated effector functions; HIV-1; nanobodies; neutralization
تواريخ الأحداث: Date Created: 20221209 Latest Revision: 20221209
رمز التحديث: 20221209
مُعرف محوري في PubMed: PMC9723857
DOI: 10.3389/fimmu.2022.1091668
PMID: 36483568
قاعدة البيانات: MEDLINE
الوصف
تدمد:1664-3224
DOI:10.3389/fimmu.2022.1091668